Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
05 12 2022
Historique:
received: 18 01 2022
revised: 29 03 2022
accepted: 01 09 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 28 9 2022
Statut: ppublish

Résumé

Neonatal herpes simplex virus (nHSV) infections often result in significant mortality and neurological morbidity despite antiviral drug therapy. Maternally transferred herpes simplex virus (HSV)-specific antibodies reduce the risk of clinically overt nHSV, but this observation has not been translationally applied. Using a neonatal mouse model, we tested the hypothesis that passive transfer of HSV-specific human mAbs can prevent mortality and morbidity associated with nHSV. The mAbs were expressed in vivo via vectored immunoprophylaxis or recombinantly. Through these maternally derived routes or through direct administration to pups, diverse mAbs to HSV glycoprotein D protected against neonatal HSV-1 and HSV-2 infection. Using in vivo bioluminescent imaging, both pre- and post-exposure mAb treatment significantly reduced viral load in mouse pups. Together these studies support the notion that HSV-specific mAb-based therapies could prevent or improve HSV infection outcomes in neonates.

Identifiants

pubmed: 36156707
pii: 213499
doi: 10.1084/jem.20220110
pmc: PMC9516843
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Viral 0
Antiviral Agents 0
Glycoproteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NEI NIH HHS
ID : R01 EY009083
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI098681
Pays : United States
Organisme : NIDA NIH HHS
ID : DP2 DA040254
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007363
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI145825
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI147714
Pays : United States

Informations de copyright

© 2022 Backes et al.

Références

N Engl J Med. 1997 Aug 21;337(8):509-15
pubmed: 9262493
N Engl J Med. 2021 Jul 29;385(5):436-444
pubmed: 34320288
Phys Med Biol. 2020 Apr 28;65(9):095004
pubmed: 32135522
Pediatrics. 2011 Dec;128(6):1153-60
pubmed: 22123868
Nature. 1991 Apr 4;350(6317):423-6
pubmed: 1901381
J Gen Virol. 1973 Mar;18(3):329-46
pubmed: 4348796
PLoS Pathog. 2018 May 23;14(5):e1007095
pubmed: 29791513
J Infect Dis. 2002 Jun 1;185(11):1550-60
pubmed: 12023760
J Infect Dis. 2021 Dec 1;224(11):1916-1924
pubmed: 34009371
J Virol. 2002 Dec;76(23):12149-61
pubmed: 12414955
J Pediatr. 2013 Aug;163(2):424-8
pubmed: 23507026
Nature. 2011 Nov 30;481(7379):81-4
pubmed: 22139420
MAbs. 2018 Oct;10(7):1098-1110
pubmed: 29947573
Nat Biotechnol. 2013 Jul;31(7):647-52
pubmed: 23728362
J Clin Microbiol. 1998 Nov;36(11):3198-204
pubmed: 9774565
Hum Gene Ther. 2016 Nov;27(11):916-925
pubmed: 27412455
Nat Med. 2022 May;28(5):1022-1030
pubmed: 35411076
Pediatr Infect Dis J. 1998 Feb;17(2):110-5
pubmed: 9493805
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12528-32
pubmed: 25114213
Virology. 1996 Jan 1;215(1):101-6
pubmed: 8553581
PLoS Med. 2021 Feb 3;18(2):e1003495
pubmed: 33534791
J Immunol. 2009 Mar 1;182(5):2583-9
pubmed: 19234152
Signal Transduct Target Ther. 2021 Feb 8;6(1):53
pubmed: 33558455
Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S950-2
pubmed: 1664132
J Pediatr. 1973 Apr;82(4):707-18
pubmed: 4572747
CMAJ. 2021 Jul 26;193(29):E1129-E1136
pubmed: 34312166
JAMA. 2003 Jan 8;289(2):203-9
pubmed: 12517231
J Gen Virol. 1993 Sep;74 ( Pt 9):1859-69
pubmed: 8397283
Infect Immun. 1979 Feb;23(2):305-11
pubmed: 217828
Biomed Opt Express. 2020 Jun 08;11(7):3633-3647
pubmed: 33014556
J Immunol Methods. 2017 Nov;450:66-72
pubmed: 28780040
Lancet HIV. 2019 Apr;6(4):e230-e239
pubmed: 30885692
Pediatr Res. 2014 Dec;76(6):528-34
pubmed: 25198371
Pediatrics. 1980 Oct;66(4):489-94
pubmed: 6253866
Pediatr Infect Dis J. 1998 Sep;17(9):787-91
pubmed: 9779762
Nat Biotechnol. 2010 Feb;28(2):157-9
pubmed: 20081867
Sex Transm Dis. 2021 Aug 1;48(8S):S4-S10
pubmed: 33967231
Sci Transl Med. 2014 Sep 17;6(254):254ra129
pubmed: 25232181
mBio. 2017 Jul 5;8(4):
pubmed: 28679745
Acta Crystallogr D Biol Crystallogr. 2013 Oct;69(Pt 10):1935-45
pubmed: 24100313
Obstet Gynecol. 2006 Jul;108(1):141-7
pubmed: 16816068
J Gen Virol. 1987 Mar;68 ( Pt 3):715-25
pubmed: 3029300
Sci Transl Med. 2019 Apr 10;11(487):
pubmed: 30971454
J Virol. 2001 Jun;75(11):5069-75
pubmed: 11333887
J Gen Virol. 1982 May;60(Pt 1):25-9
pubmed: 6178800
J Virol. 2017 Sep 12;91(19):
pubmed: 28701403
J Clin Invest. 1990 Jul;86(1):273-8
pubmed: 2164044
Lancet Glob Health. 2017 Mar;5(3):e300-e309
pubmed: 28153513
Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):355-9
pubmed: 8278393
J Biol Chem. 2014 Feb 7;289(6):3571-90
pubmed: 24311787
N Engl J Med. 1991 May 2;324(18):1247-52
pubmed: 1849612
J Biol Chem. 2001 Mar 2;276(9):6591-604
pubmed: 11096108
JAMA. 1999 Jul 28;282(4):331-40
pubmed: 10432030
N Engl J Med. 2012 Jan 5;366(1):34-43
pubmed: 22216840
J Virol. 2017 Nov 14;91(23):
pubmed: 28904192
N Engl J Med. 1991 Feb 14;324(7):450-4
pubmed: 1988830
Nat Med. 2014 Mar;20(3):296-300
pubmed: 24509526
JAMA. 1986 Oct 10;256(14):1904-8
pubmed: 3020264
Pediatrics. 2019 Apr;143(4):
pubmed: 30923058
J Infect Dis. 2020 Feb 18;221(5):729-738
pubmed: 31599942
J Virol. 2013 Jan;87(1):474-81
pubmed: 23097453
J Immunol Methods. 2012 Dec 14;386(1-2):117-23
pubmed: 23023091
J Infect Dis. 1989 Nov;160(5):770-6
pubmed: 2553825
Obstet Gynecol. 2020 Feb;135(2):e51-e72
pubmed: 31977795
Infect Immun. 1980 Dec;30(3):847-50
pubmed: 6262242
Clin Obstet Gynecol. 1982 Sep;25(3):563-76
pubmed: 6290121
J Gen Virol. 1968 May;2(3):357-64
pubmed: 4300104
Infect Immun. 1980 Aug;29(2):532-8
pubmed: 7216423
J Infect Dis. 1975 Jan;131(1):51-7
pubmed: 162925
J Infect Dis. 2020 Jul 23;222(4):628-636
pubmed: 31681963
N Engl J Med. 2014 Apr 3;370(14):1316-26
pubmed: 24693891
J Virol. 2020 May 18;94(11):
pubmed: 32188735
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6760-5
pubmed: 23569258
Infect Immun. 1981 Oct;34(1):192-9
pubmed: 6271681
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17916-20
pubmed: 19805039
Drug Discov Today. 2016 Apr;21(4):682-91
pubmed: 26976690
N Engl J Med. 2009 Oct 1;361(14):1376-85
pubmed: 19797284

Auteurs

Iara M Backes (IM)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH.
Thayer School of Engineering, Dartmouth College, Hanover, NH.

Brook K Byrd (BK)

Thayer School of Engineering, Dartmouth College, Hanover, NH.

Matthew D Slein (MD)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH.
Thayer School of Engineering, Dartmouth College, Hanover, NH.

Chaya D Patel (CD)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH.

Sean A Taylor (SA)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH.

Callaghan R Garland (CR)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH.

Scott W MacDonald (SW)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA.

Alejandro B Balazs (AB)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA.

Scott C Davis (SC)

Thayer School of Engineering, Dartmouth College, Hanover, NH.

Margaret E Ackerman (ME)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH.
Thayer School of Engineering, Dartmouth College, Hanover, NH.

David A Leib (DA)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH